United States Biosimilar Drug Industry 2016 Deep Market Research Report

1 Industry Overview

1.1 Definition and Specifications of Biosimilar Drug

1.1.1 Definition of Biosimilar Drug

1.1.2 Specifications of Biosimilar Drug

1.2 Classification of Biosimilar Drug

1.3 Applications of Biosimilar Drug

1.4 Industry Chain Structure of Biosimilar Drug

1.5 Industry Overview of Biosimilar Drug

1.6 Industry Policy Analysis of Biosimilar Drug

1.7 Industry News Analysis of Biosimilar Drug

2 Manufacturing Cost Structure Analysis of Biosimilar Drug

2.1 Bill of Materials (BOM) of Biosimilar Drug

2.2 BOM Price Analysis of Biosimilar Drug

2.3 Labor Cost Analysis of Biosimilar Drug

2.4 Depreciation Cost Analysis of Biosimilar Drug

2.5 Manufacturing Cost Structure Analysis of Biosimilar Drug

2.6 Manufacturing Process Analysis of Biosimilar Drug

2.7 United States Price, Cost and Gross of Biosimilar Drug 2011-2016

3 Technical Data and Manufacturing Plants Analysis

3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015

3.2 Manufacturing Plants Distribution of United States Key Biosimilar Drug Manufacturers in 2015

3.3 R&D Status and Technology Source of United States Biosimilar Drug Key Manufacturers in 2015

3.4 Raw Materials Sources Analysis of United States Biosimilar Drug Key Manufacturers in 2015

4 Production Analysis of Biosimilar Drug by Regions, Type, and Applications

4.1 United States Production of Biosimilar Drug by Regions 2011-2016

4.2 United States Production of Biosimilar Drug by Type 2011-2016

4.3 United States Sales of Biosimilar Drug by Applications 2011-2016

4.4 Price Analysis of United States Biosimilar Drug Key Manufacturers in 2015

4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Biosimilar Drug 2011-2016

5 Consumption Volume and Consumption Value Analysis of Biosimilar Drug by Regions

5.1 United States Consumption Volume of Biosimilar Drug by Regions 2011-2016

5.2 United States Consumption Value of Biosimilar Drug by Regions 2011-2016

5.3 United States Consumption Price Analysis of Biosimilar Drug by Regions 2011-2016

6 Analysis of Biosimilar Drug Production, Supply, Sales and Market Status 2011-2016

6.1 Capacity, Production, Sales, and Revenue of Biosimilar Drug 2011-2016

6.2 Production Market Share and Sales Market Share Analysis of Biosimilar Drug 2014-2015

6.3 Sales Overview of Biosimilar Drug 2011-2016

6.4 Supply, Consumption and Gap of Biosimilar Drug 2011-2016

6.5 Import, Export and Consumption of Biosimilar Drug 2011-2016

6.6 Cost, Price, Revenue and Gross Margin of Biosimilar Drug 2011-2016

7 Analysis of Biosimilar Drug Industry Key Manufacturers

7.1 Hospira

7.1.1 Company Profile

7.1.2 Product Picture and Specifications

7.1.2.1 Type I

7.1.2.2 Type II

7.1.2.3 Type III

7.1.3 Capacity, Production, Price, Cost, Gross and Revenue

7.1.4 Contact Information

7.2 Sandoz

7.2.1 Company Profile

7.2.2 Product Picture and Specifications

7.2.2.1 Type I

7.2.2.2 Type II

7.2.2.3 Type III

7.2.3 Capacity, Production, Price, Cost, Gross and Revenue

7.2.4 Contact Information

7.3 Teva Pharmaceutical Industries

7.3.1 Company Profile

7.3.2 Product Picture and Specifications

7.3.2.1 Type I

7.3.2.2 Type II

7.3.2.3 Type III

7.3.3 Capacity, Production, Price, Cost, Gross and Revenue

7.3.4 Contact Information

7.4 Pfizer

7.4.1 Company Profile

7.4.2 Product Picture and Specifications

7.4.2.1 Type I

7.4.2.2 Type II

7.4.2.3 Type III

7.4.3 Capacity, Production, Price, Cost, Gross and Revenue

7.4.4 Contact Information

7.5 Merck Sharp & Dohme

7.5.1 Company Profile

7.5.2 Product Picture and Specifications

7.5.2.1 Type I

7.5.2.2 Type II

7.5.2.3 Type III

7.5.3 Capacity, Production, Price, Cost, Gross and Revenue

7.5.4 Contact Information

7.6 Celltrion

7.6.1 Company Profile

7.6.2 Product Picture and Specifications

7.6.2.1 Type I

7.6.2.2 Type II

7.6.2.3 Type III

7.6.3 Capacity, Production, Price, Cost, Gross and Revenue

7.6.4 Contact Information

7.7 Amgen

7.7.1 Company Profile

7.7.2 Product Picture and Specifications

7.7.2.1 Type I

7.7.2.2 Type II

7.7.2.3 Type III

7.7.3 Capacity, Production, Price, Cost, Gross and Revenue

7.7.4 Contact Information

7.8 Biogen

7.8.1 Company Profile

7.8.2 Product Picture and Specifications

7.8.2.1 Type I

7.8.2.2 Type II

7.8.2.3 Type III

7.8.3 Capacity, Production, Price, Cost, Gross and Revenue

7.8.4 Contact Information

7.9 Mylan

7.9.1 Company Profile

7.9.2 Product Picture and Specifications

7.9.2.1 Type I

7.9.2.2 Type II

7.9.2.3 Type III

7.9.3 Capacity, Production, Price, Cost, Gross and Revenue

7.9.4 Contact Information

7.10 Biocon

7.10.1 Company Profile

7.10.2 Product Picture and Specifications

7.10.2.1 Type I

7.10.2.2 Type II

7.10.2.3 Type III

7.10.3 Capacity, Production, Price, Cost, Gross and Revenue

7.10.4 Contact Information

7.11 Dr. Reddy’s Laboratories

7.11.1 Company Profile

7.11.2 Product Picture and Specifications

7.11.2.1 Type I

7.11.2.2 Type II

7.11.2.3 Type III

7.11.3 Capacity, Production, Price, Cost, Gross and Revenue

7.11.4 Contact Information

7.12 Boehringer Ingelheim GmbH

7.12.1 Company Profile

7.12.2 Product Picture and Specifications

7.12.2.1 Type I

7.12.2.2 Type II

7.12.2.3 Type III

7.12.3 Capacity, Production, Price, Cost, Gross and Revenue

7.12.4 Contact Information

7.13 Intas Pharmaceuticals

7.13.1 Company Profile

7.13.2 Product Picture and Specifications

7.13.2.1 Type I

7.13.2.2 Type II

7.13.2.3 Type III

7.13.3 Capacity, Production, Price, Cost, Gross and Revenue

7.13.4 Contact Information

7.14 LG Life Sciences

7.14.1 Company Profile

7.14.2 Product Picture and Specifications

7.14.2.1 Type I

7.14.2.2 Type II

7.14.2.3 Type III

7.14.3 Capacity, Production, Price, Cost, Gross and Revenue

7.14.4 Contact Information

7.15 Emcure Pharmaceuticals

7.15.1 Company Profile

7.15.2 Product Picture and Specifications

7.15.2.1 Type I

7.15.2.2 Type II

7.15.2.3 Type III

7.15.3 Capacity, Production, Price, Cost, Gross and Revenue

7.15.4 Contact Information

7.16 Probiomed

7.16.1 Company Profile

7.16.2 Product Picture and Specifications

7.16.2.1 Type I

7.16.2.2 Type II

7.16.2.3 Type III

7.16.3 Capacity, Production, Price, Cost, Gross and Revenue

7.16.4 Contact Information

7.17 Biosidus

7.17.1 Company Profile

7.17.2 Product Picture and Specifications

7.17.2.1 Type I

7.17.2.2 Type II

7.17.2.3 Type III

7.17.3 Capacity, Production, Price, Cost, Gross and Revenue

7.17.4 Contact Information

7.18 3SBio

7.18.1 Company Profile

7.18.2 Product Picture and Specifications

7.18.2.1 Type I

7.18.2.2 Type II

7.18.2.3 Type III

7.18.3 Capacity, Production, Price, Cost, Gross and Revenue

7.18.4 Contact Information

7.19 WOCKHARDT

7.19.1 Company Profile

7.19.2 Product Picture and Specifications

7.19.2.1 Type I

7.19.2.2 Type II

7.19.2.3 Type III

7.19.3 Capacity, Production, Price, Cost, Gross and Revenue

7.19.4 Contact Information

7.20 Sun Pharmaceutical Industries

7.20.1 Company Profile

7.20.2 Product Picture and Specifications

7.20.2.1 Type I

7.20.2.2 Type II

7.20.2.3 Type III

7.20.3 Capacity, Production, Price, Cost, Gross and Revenue

7.20.4 Contact Information

7.21 Shanghai Fosun Pharmaceutical

7.21.1 Company Profile

7.21.2 Product Picture and Specifications

7.21.2.1 Type I

7.21.2.2 Type II

7.21.2.3 Type III

7.21.3 Capacity, Production, Price, Cost, Gross and Revenue

7.21.4 Contact Information

7.22 Qilu Pharmaceutical

7.22.1 Company Profile

7.22.2 Product Picture and Specifications

7.22.2.1 Type I

7.22.2.2 Type II

7.22.2.3 Type III

7.22.3 Capacity, Production, Price, Cost, Gross and Revenue

7.22.4 Contact Information

7.23 Allergan

7.23.1 Company Profile

7.23.2 Product Picture and Specifications

7.23.2.1 Type I

7.23.2.2 Type II

7.23.2.3 Type III

7.23.3 Capacity, Production, Price, Cost, Gross and Revenue

7.23.4 Contact Information

7.24 Dongbao

7.24.1 Company Profile

7.24.2 Product Picture and Specifications

7.24.2.1 Type I

7.24.2.2 Type II

7.24.2.3 Type III

7.24.3 Capacity, Production, Price, Cost, Gross and Revenue

7.24.4 Contact Information

7.25 Samsung Biologics

7.25.1 Company Profile

7.25.2 Product Picture and Specifications

7.25.2.1 Type I

7.25.2.2 Type II

7.25.2.3 Type III

7.25.3 Capacity, Production, Price, Cost, Gross and Revenue

7.25.4 Contact Information

7.26 Zydus Cadila.

7.26.1 Company Profile

7.26.2 Product Picture and Specifications

7.26.2.1 Type I

7.26.2.2 Type II

7.26.2.3 Type III

7.26.3 Capacity, Production, Price, Cost, Gross and Revenue

7.26.4 Contact Information

7.27 Dong-A Pharmaceutical

7.27.1 Company Profile

7.27.2 Product Picture and Specifications

7.27.2.1 Type I

7.27.2.2 Type II

7.27.2.3 Type III

7.27.3 Capacity, Production, Price, Cost, Gross and Revenue

7.27.4 Contact Information

8 Price and Gross Margin Analysis

8.1 Analysis of Price

8.2 Gross Margin Analysis

8.3 Price Comparison by Regions

8.4 Price Analysis of Different Biosimilar Drug Product Types

8.5 Market Share Analysis of Different Biosimilar Drug Price Levels

8.6 Gross Margin Analysis of Different Biosimilar Drug Applications

9 Marketing Trader or Distributor Analysis of Biosimilar Drug

9.1 Marketing Channels Status of Biosimilar Drug

9.2 Traders or Distributors of Biosimilar Drug with Contact Information

9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Biosimilar Drug

9.4 United States Import, Export and Trade Analysis of Biosimilar Drug

10 Development Trend of Biosimilar Drug Industry 2016-2021

10.1 Capacity and Production Overview of Biosimilar Drug 2016-2021

10.2 Production Market Share by Product Types of Biosimilar Drug 2016-2021

10.3 Sales and Sales Revenue Overview of Biosimilar Drug 2016-2021

10.4 United States Sales of Biosimilar Drug by Applications 2016-2021

10.5 Import, Export and Consumption of Biosimilar Drug 2016-2021

10.6 Cost, Price, Revenue and Gross Margin of Biosimilar Drug 2016-2021

11 Industry Chain Suppliers of Biosimilar Drug with Contact Information

11.1 Major Raw Materials Suppliers of Biosimilar Drug with Contact Information

11.2 Manufacturing Equipment Suppliers of Biosimilar Drug with Contact Information

11.3 Major Players of Biosimilar Drug with Contact Information

11.4 Key Consumers of Biosimilar Drug with Contact Information

11.5 Supply Chain Relationship Analysis of Biosimilar Drug

12 New Project Investment Feasibility Analysis of Biosimilar Drug

12.1 New Project SWOT Analysis of Biosimilar Drug

12.2 New Project Investment Feasibility Analysis of Biosimilar Drug

13 Conclusion of the United States Biosimilar Drug Industry 2016 Market Research Report

Figure Picture of Biosimilar Drug

Table Product Specifications of Biosimilar Drug

Table Classification of Biosimilar Drug

Figure United States Sales Market Share of Biosimilar Drug by Product Types in 2015

Table Applications of Biosimilar Drug

Figure United States Sales Market Share of Biosimilar Drug by Applications in 2015

Figure Industry Chain Structure of Biosimilar Drug

Table United States Industry Overview of Biosimilar Drug

Table Industry Policy of Biosimilar Drug

Table Industry News List of Biosimilar Drug

Table Bill of Materials (BOM) of Biosimilar Drug

Table Bill of Materials (BOM) Price of Biosimilar Drug

Table Labor Cost of Biosimilar Drug

Table Depreciation Cost of Biosimilar Drug

Table Manufacturing Cost Structure Analysis of Biosimilar Drug in 2015

Figure Manufacturing Process Analysis of Biosimilar Drug

Table United States Price Analysis of Biosimilar Drug 2011-2016 (USD/Dose)

Table United States Cost Analysis of Biosimilar Drug 2011-2016 (USD/Dose)

Table United States Gross Analysis of Biosimilar Drug 2011-2016

Table Capacity (K Dose) and Commercial Production Date of United States Biosimilar Drug Key Manufacturers in 2015

Table Manufacturing Plants Distribution of United States Key Biosimilar Drug Manufacturers in 2015

Table R&D Status and Technology Source of United States Biosimilar Drug Key Manufacturers in 2015

Table Raw Materials Sources Analysis of United States and United States Biosimilar Drug Key Manufacturers in 2015

Table United States Production of Biosimilar Drug by Regions 2011-2016 (K Dose)

Table United States Production Market Share of Biosimilar Drug by Regions 2011-2016

Figure United States Production Market Share of Biosimilar Drug by Regions in 2014

Figure United States Production Market Share of Biosimilar Drug by Regions in 2015

Table United States Production of Biosimilar Drug by Types in 2011-2016 (K Dose)

Table United States Production Market Share of Biosimilar Drug by Type in 2011-2016

Figure United States Production Market Share of Biosimilar Drug by Type in 2014

Figure United States Production Market Share of Biosimilar Drug by Type in 2015

Table United States Sales of Biosimilar Drug by Applications 2011-2016 (K Dose)

Table United States Production Market Share of Biosimilar Drug by Applications 2011-2016

Figure United States Production Market Share of Biosimilar Drug by Applications in 2014

Figure United States Production Market Share of Biosimilar Drug by Applications in 2015

Table Price Comparison of United States Biosimilar Drug Key Manufacturers in 2015 (USD/Dose)

Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Biosimilar Drug 2011-2016

Table United States Consumption Volume of Biosimilar Drug by Regions 2011-2016 (K Dose)

Table United States Consumption Volume Market Share of Biosimilar Drug by Regions 2011-2016

Figure United States Consumption Volume Market Share of Biosimilar Drug by Regions in 2014

Figure United States Consumption Volume Market Share of Biosimilar Drug by Regions in 2015

Table United States Consumption Value of Biosimilar Drug by Regions 2011-2016 (M USD)

Table United States Consumption Value Market Share of Biosimilar Drug by Regions 2011-2016

Figure United States Consumption Value Market Share of Biosimilar Drug by Regions in 2014

Figure United States Consumption Value Market Share of Biosimilar Drug by Regions in 2015

Table Consumption Price of Biosimilar Drug by Regions 2011-2016 (USD/Dose)

Table United States and Major Manufacturers Capacity of Biosimilar Drug 2011-2016 (K Dose)

Table United States Capacity Market Share of Major Biosimilar Drug Manufacturers 2011-2016

Table United States and Major Manufacturers Production of Biosimilar Drug 2011-2016 (K Dose)

Table United States Production Market Share of Major Biosimilar Drug Manufacturers 2011-2016

Table United States and Major Manufacturers Sales of Biosimilar Drug 2011-2016 (K Dose)

Table United States Sales Market Share of Major Biosimilar Drug Manufacturers 2011-2016

Table United States and Major Manufacturers Sales Revenue of Biosimilar Drug 2011-2016 (M USD)

Table United States Sales Revenue Market Share of Major Biosimilar Drug Manufacturers 2011-2016

Figure United States Capacity (K Dose), Production (K Dose) and Growth Rate of Biosimilar Drug 2011-2016

Figure United States Capacity Utilization Rate of Biosimilar Drug 2011-2016

Figure United States Sales Revenue (M USD) and Growth Rate of Biosimilar Drug 2011-2016

Figure United States Production Market Share of Major Biosimilar Drug Manufacturers in 2014

Figure United States Production Market Share of Major Biosimilar Drug Manufacturers in 2015

Figure United States Sales Market Share of Major Biosimilar Drug Manufacturers in 2014

Figure United States Sales Market Share of Major Biosimilar Drug Manufacturers in 2015

Figure United States Sales (K Dose) and Growth Rate of Biosimilar Drug 2011-2016

Table United States Supply, Consumption and Gap of Biosimilar Drug 2011-2016 (K Dose)

Table United States Import, Export and Consumption of Biosimilar Drug 2011-2016 (K Dose)

Table Price of United States Biosimilar Drug Major Manufacturers 2011-2016 (USD/Dose)

Table Gross Margin of United States Biosimilar Drug Major Manufacturers 2011-2016

Table United States and Major Manufacturers Revenue of Biosimilar Drug 2011-2016 (M USD)

Table United States Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Biosimilar Drug 2011-2016

Table Hospira Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biosimilar Drug Picture and Specifications of Hospira

Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Hospira 2011-2016

Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Hospira 2011-2016

Figure Biosimilar Drug Production (K Dose) and United States Market Share of Hospira 2011-2016

Table Hospira Biosimilar Drug SWOT Analysis

Table Sandoz Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biosimilar Drug Picture and Specifications of Sandoz

Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Sandoz 2011-2016

Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Sandoz 2011-2016

Figure Biosimilar Drug Production (K Dose) and United States Market Share of Sandoz 2011-2016

Table Sandoz Biosimilar Drug SWOT Analysis

Table Teva Pharmaceutical Industries Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biosimilar Drug Picture and Specifications of Teva Pharmaceutical Industries

Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Teva Pharmaceutical Industries 2011-2016

Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Teva Pharmaceutical Industries 2011-2016

Figure Biosimilar Drug Production (K Dose) and United States Market Share of Teva Pharmaceutical Industries 2011-2016

Table Teva Pharmaceutical Industries Biosimilar Drug SWOT Analysis

Table Pfizer Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biosimilar Drug Picture and Specifications of Pfizer

Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Pfizer 2011-2016

Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Pfizer 2011-2016

Figure Biosimilar Drug Production (K Dose) and United States Market Share of Pfizer 2011-2016

Table Pfizer Biosimilar Drug SWOT Analysis

Table Merck Sharp & Dohme Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biosimilar Drug Picture and Specifications of Merck Sharp & Dohme

Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Merck Sharp & Dohme 2011-2016

Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Merck Sharp & Dohme 2011-2016

Figure Biosimilar Drug Production (K Dose) and United States Market Share of Merck Sharp & Dohme 2011-2016

Table Merck Sharp & Dohme Biosimilar Drug SWOT Analysis

Table Celltrion Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biosimilar Drug Picture and Specifications of Celltrion

Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Celltrion 2011-2016

Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Celltrion 2011-2016

Figure Biosimilar Drug Production (K Dose) and United States Market Share of Celltrion 2011-2016

Table Celltrion Biosimilar Drug SWOT Analysis

Table Amgen Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biosimilar Drug Picture and Specifications of Amgen

Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Amgen 2011-2016

Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Amgen 2011-2016

Figure Biosimilar Drug Production (K Dose) and United States Market Share of Amgen 2011-2016

Table Amgen Biosimilar Drug SWOT Analysis

Table Biogen Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biosimilar Drug Picture and Specifications of Biogen

Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Biogen 2011-2016

Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Biogen 2011-2016

Figure Biosimilar Drug Production (K Dose) and United States Market Share of Biogen 2011-2016

Table Biogen Biosimilar Drug SWOT Analysis

Table Mylan Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biosimilar Drug Picture and Specifications of Mylan

Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Mylan 2011-2016

Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Mylan 2011-2016

Figure Biosimilar Drug Production (K Dose) and United States Market Share of Mylan 2011-2016

Table Mylan Biosimilar Drug SWOT Analysis

Table Biocon Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biosimilar Drug Picture and Specifications of Biocon

Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Biocon 2011-2016

Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Biocon 2011-2016

Figure Biosimilar Drug Production (K Dose) and United States Market Share of Biocon 2011-2016

Table Biocon Biosimilar Drug SWOT Analysis

Table Dr. Reddy’s Laboratories Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biosimilar Drug Picture and Specifications of Dr. Reddy’s Laboratories

Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Dr. Reddy’s Laboratories 2011-2016

Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Dr. Reddy’s Laboratories 2011-2016

Figure Biosimilar Drug Production (K Dose) and United States Market Share of Dr. Reddy’s Laboratories 2011-2016

Table Dr. Reddy’s Laboratories Biosimilar Drug SWOT Analysis

Table Boehringer Ingelheim GmbH Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biosimilar Drug Picture and Specifications of Boehringer Ingelheim GmbH

Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Boehringer Ingelheim GmbH 2011-2016

Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Boehringer Ingelheim GmbH 2011-2016

Figure Biosimilar Drug Production (K Dose) and United States Market Share of Boehringer Ingelheim GmbH 2011-2016

Table Boehringer Ingelheim GmbH Biosimilar Drug SWOT Analysis

Table Intas Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biosimilar Drug Picture and Specifications of Intas Pharmaceuticals

Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Intas Pharmaceuticals 2011-2016

Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Intas Pharmaceuticals 2011-2016

Figure Biosimilar Drug Production (K Dose) and United States Market Share of Intas Pharmaceuticals 2011-2016

Table Intas Pharmaceuticals Biosimilar Drug SWOT Analysis

Table LG Life Sciences Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biosimilar Drug Picture and Specifications of LG Life Sciences

Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of LG Life Sciences 2011-2016

Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of LG Life Sciences 2011-2016

Figure Biosimilar Drug Production (K Dose) and United States Market Share of LG Life Sciences 2011-2016

Table LG Life Sciences Biosimilar Drug SWOT Analysis

Table Emcure Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biosimilar Drug Picture and Specifications of Emcure Pharmaceuticals

Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Emcure Pharmaceuticals 2011-2016

Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Emcure Pharmaceuticals 2011-2016

Figure Biosimilar Drug Production (K Dose) and United States Market Share of Emcure Pharmaceuticals 2011-2016

Table Emcure Pharmaceuticals Biosimilar Drug SWOT Analysis

Table Probiomed Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biosimilar Drug Picture and Specifications of Probiomed

Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Probiomed 2011-2016

Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Probiomed 2011-2016

Figure Biosimilar Drug Production (K Dose) and United States Market Share of Probiomed 2011-2016

Table Probiomed Biosimilar Drug SWOT Analysis

Table Biosidus Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biosimilar Drug Picture and Specifications of Biosidus

Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Biosidus 2011-2016

Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Biosidus 2011-2016

Figure Biosimilar Drug Production (K Dose) and United States Market Share of Biosidus 2011-2016

Table Biosidus Biosimilar Drug SWOT Analysis

Table 3SBio Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biosimilar Drug Picture and Specifications of 3SBio

Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of 3SBio 2011-2016

Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of 3SBio 2011-2016

Figure Biosimilar Drug Production (K Dose) and United States Market Share of 3SBio 2011-2016

Table 3SBio Biosimilar Drug SWOT Analysis

Table WOCKHARDT Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biosimilar Drug Picture and Specifications of WOCKHARDT

Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of WOCKHARDT 2011-2016

Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of WOCKHARDT 2011-2016

Figure Biosimilar Drug Production (K Dose) and United States Market Share of WOCKHARDT 2011-2016

Table WOCKHARDT Biosimilar Drug SWOT Analysis

Table Sun Pharmaceutical Industries Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biosimilar Drug Picture and Specifications of Sun Pharmaceutical Industries

Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Sun Pharmaceutical Industries 2011-2016

Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Sun Pharmaceutical Industries 2011-2016

Figure Biosimilar Drug Production (K Dose) and United States Market Share of Sun Pharmaceutical Industries 2011-2016

Table Sun Pharmaceutical Industries Biosimilar Drug SWOT Analysis

Table Shanghai Fosun Pharmaceutical Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biosimilar Drug Picture and Specifications of Shanghai Fosun Pharmaceutical

Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Shanghai Fosun Pharmaceutical 2011-2016

Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Shanghai Fosun Pharmaceutical 2011-2016

Figure Biosimilar Drug Production (K Dose) and United States Market Share of Shanghai Fosun Pharmaceutical 2011-2016

Table Shanghai Fosun Pharmaceutical Biosimilar Drug SWOT Analysis

Table Qilu Pharmaceutical Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biosimilar Drug Picture and Specifications of Qilu Pharmaceutical

Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Qilu Pharmaceutical 2011-2016

Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Qilu Pharmaceutical 2011-2016

Figure Biosimilar Drug Production (K Dose) and United States Market Share of Qilu Pharmaceutical 2011-2016

Table Qilu Pharmaceutical Biosimilar Drug SWOT Analysis

Table Allergan Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biosimilar Drug Picture and Specifications of Allergan

Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Allergan 2011-2016

Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Allergan 2011-2016

Figure Biosimilar Drug Production (K Dose) and United States Market Share of Allergan 2011-2016

Table Allergan Biosimilar Drug SWOT Analysis

Table Dongbao Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biosimilar Drug Picture and Specifications of Dongbao

Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Dongbao 2011-2016

Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Dongbao 2011-2016

Figure Biosimilar Drug Production (K Dose) and United States Market Share of Dongbao 2011-2016

Table Dongbao Biosimilar Drug SWOT Analysis

Table Samsung Biologics Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biosimilar Drug Picture and Specifications of Samsung Biologics

Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Samsung Biologics 2011-2016

Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Samsung Biologics 2011-2016

Figure Biosimilar Drug Production (K Dose) and United States Market Share of Samsung Biologics 2011-2016

Table Samsung Biologics Biosimilar Drug SWOT Analysis

Table Zydus Cadila. Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biosimilar Drug Picture and Specifications of Zydus Cadila.

Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Zydus Cadila. 2011-2016

Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Zydus Cadila. 2011-2016

Figure Biosimilar Drug Production (K Dose) and United States Market Share of Zydus Cadila. 2011-2016

Table Zydus Cadila. Biosimilar Drug SWOT Analysis

Table Dong-A Pharmaceutical Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biosimilar Drug Picture and Specifications of Dong-A Pharmaceutical

Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Dong-A Pharmaceutical 2011-2016

Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Dong-A Pharmaceutical 2011-2016

Figure Biosimilar Drug Production (K Dose) and United States Market Share of Dong-A Pharmaceutical 2011-2016

Table Dong-A Pharmaceutical Biosimilar Drug SWOT Analysis

Table Biosimilar Drug Price by Regions 2011-2016

Table Biosimilar Drug Price by Product Types 2011-2016

Table Biosimilar Drug Price by Companies 2011-2016

Table Biosimilar Drug Gross Margin by Companies 2011-2016

Table Price Comparison of Biosimilar Drug by Regions 2011-2016 (USD/Dose)

Table Price of Different Biosimilar Drug Product Types (USD/Dose)

Table Market Share of Different Biosimilar Drug Price Level

Table Gross Margin of Different Biosimilar Drug Applications

Table Marketing Channels Status of Biosimilar Drug

Table Traders or Distributors of Biosimilar Drug with Contact Information

Table Ex-work Price, Channel Price and End Buyer Price of Biosimilar Drug (USD/Dose) in 2015

Table United States Import, Export, and Trade of Biosimilar Drug (K Dose)

Figure United States Capacity (K Dose), Production (K Dose) and Growth Rate of Biosimilar Drug 2016-2021

Figure United States Capacity Utilization Rate of Biosimilar Drug 2016-2021

Table United States Biosimilar Drug Production by Type 2016-2021 (K Dose)

Table United States Biosimilar Drug Production Market Share by Type 2016-2021

Figure United States Production Market Share of Biosimilar Drug by Type in 2021

Figure United States Sales (K Dose) and Growth Rate of Biosimilar Drug 2016-2021

Figure United States Sales Revenue (Million USD) and Growth Rate of Biosimilar Drug 2016-2021

Figure United States Sales of Biosimilar Drug by Applications 2016-2021 (K Dose)

Table United States Production Market Share of Biosimilar Drug by Applications 2016-2021

Figure United States Production Market Share of Biosimilar Drug by Applications in 2021

Table United States Production, Import, Export and Consumption of Biosimilar Drug 2016-2021 (K Dose)

Table United States Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Biosimilar Drug 2016-2021

Table Major Raw Materials Suppliers of Biosimilar Drug with Contact Information

Table Manufacturing Equipment Suppliers of Biosimilar Drug with Contact Information

Table Major Players of Biosimilar Drug with Contact Information

Table Key Consumers of Biosimilar Drug with Contact Information

Table Supply Chain Relationship Analysis of Biosimilar Drug

Table New Project SWOT Analysis of Biosimilar Drug

Table New Project Investment Feasibility Analysis of Biosimilar Drug

Table Part of Interviewees Record List